JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online May 14, 2009, 10.2967/jnumed.108.061119
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kudo, T.
Right arrow Articles by Saji, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kudo, T.
Right arrow Articles by Saji, H.

Imaging of HIF-1-Active Tumor Hypoxia Using a Protein Effectively Delivered to and Specifically Stabilized in HIF-1-Active Tumor Cells

Takashi Kudo1, Masashi Ueda1,2, Yuji Kuge1, Takahiro Mukai3, Shotaro Tanaka4, Maki Masutani1, Yasushi Kiyono2,5, Shinae Kizaka-Kondoh4, Masahiro Hiraoka4 and Hideo Saji1

1 Department of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan; 2 Radioisotopes Research Laboratory, Faculty of Medicine, Kyoto University Hospital, Kyoto University, Kyoto, Japan; 3 Department of Biomolecular Recognition Chemistry, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan; 4 Department of Radiation Oncology and Image-Applied Therapy, Kyoto University Graduate School of Medicine, Kyoto University, Kyoto, Japan; and 5 Biomedical Imaging Research Center, University of Fukui, Fukui, Japan


Figure 1
View larger version (26K):
[in this window]
[in a new window]

 
FIGURE 1.  Concept of hypoxia imaging using 123I-IPOS. PTD enables 123I-IPOS to be delivered to normoxic and hypoxic tissue. In normoxic tissue, POS is degraded in manner similar to HIF-1{alpha} degradation, and 123I-IBB is cleared. In contrast, in HIF-1-active tissues, POS escapes degradation and radioactivity is retained within cell. Thus, POS enables specific imaging of HIF-1-active hypoxic region.

 

Figure 2
View larger version (47K):
[in this window]
[in a new window]

 
FIGURE 2.  Analysis of fusion protein expression with sodium dodecylsulfate-polyacrylamide gel electrophoresis (lane M, molecular weight marker; lane 1, Escherichia coli lysate before IPTG induction; lane 2, E. coli lysate after IPTG induction; lane 3, protein solution after purification). New band was expressed in lane 2 at about 60 kDa, corresponding to GST-fused POS. After purification, only 1 band was detected in lane 3 at 34 kDa. IPTG = isopropyl-β-d-thiogalactopyranoside.

 

Figure 3
View larger version (7K):
[in this window]
[in a new window]

 
FIGURE 3.  Binding of 125I-IBB to POS. (A) Size-exclusion HPLC chromatogram after incubation of 125I-IBB with POS. Symbols represent radioactivity of each eluate collected every 1 min. (B) Concentration-dependent inhibition of 125I-IBB binding to POS by D-biotin. Symbols and bars represent mean and SD.

 

Figure 4
View larger version (7K):
[in this window]
[in a new window]

 
FIGURE 4.  (A) HIF-1-dependent luciferase activity in HeLa, MM1, and FM3A cells. Data were normalized by protein concentration of cells. Results are shown as ratio of activity after hypoxia to activity after normoxia. Columns and bars represent mean and SD (n = 3–6 **P < 0.01 vs. normoxia). (B) Intracellular radioactivity in HeLa, MM1, and FM3A cells after 24-h incubation under either normoxic or hypoxic conditions. Radioactivity was normalized by protein concentration of cells. Columns and bars represent mean and SD (n = 3–6 **P < 0.01 vs. normoxia). (C) Degradation of intracellularly accumulated IPOS after reoxygenation. HeLa cells were incubated with 125I-IPOS for 24 h under hypoxic conditions. Then, medium was replaced with fresh medium, and cells were subjected to further incubation under normoxic or hypoxic conditions. Results are shown as percentage of radioactivity at start of second incubation. Symbols and bars represent mean and SD (n = 3–5; *P < 0.05 vs. normoxia).

 

Figure 5
View larger version (76K):
[in this window]
[in a new window]

 
FIGURE 5.  Typical planar images of FM3A-implamted mice at 24 or 48 h after injection of 123I-IPOS. Tumors were clearly visualized in both images (arrow). Arrowheads indicate liver.

 

Figure 6
View larger version (10K):
[in this window]
[in a new window]

 
FIGURE 6.  Correlation between accumulation of 125I-IPOS and HIF-1 activity within same tumor. Ordinate represents accumulated radioactivity (%ID), and abscissa represents HIF-1-dependent luciferase activity. Correlation coefficient (R) was 0.71, indicating highly significant correlation (P < 0.05).

 

Figure 7
View larger version (82K):
[in this window]
[in a new window]

 
FIGURE 7.  Comparison between intratumoral distribution of 125I-IPOS and pimonidazole-positive hypoxic region. Typical autoradiogram (A) and pimonidazole immunohistochemical staining (B) in identical section are shown. Merged image (C) is also presented. Black arrowheads indicate area of 125I-IPOS accumulation in A and pimonidazole-positive area in B. Black arrows show areas in which both signals are positive, and red arrowheads indicate pimonidazole-positive areas without accumulation of 125I-IPOS. No signal was observed in pimonidazole-untreated tumor (D).

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2009 by the Society of Nuclear Medicine.